Welcome Note & Introduction Remarks |
FBXL4 Deficiency leads to increased clearance of Mitochondria |
Roles for mitochondrial dysfunction in Alzheimer’s disease Benedict C. Albensi, Max Rady College of Medicine - University of Manitoba, Canada |
Control of cellular bioenergetics by cytosolic calcium Franck Norbert Gellerich, Otto-von-Guericke University, Germany |
The Cell-free respiratory competent mitochondria in blood: Strategic role and application Alain Thierry, Montpellier Cancer Research Institute, INSERM, France |
Mitochondria devices: New methods to detect mitochondria dysfunction |
Down Syndrome: Role of hydrogen sulfide overproduction in the pathogenesis of mitochondrial dysfunction Csaba Szabo, Université de Fribourg, Switzerland |
Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis Don Mahad, University of Edinburgh, United Kingdom |
Mitochondrial dysfunction in autism is distinct from mitochondrial disease
|
Mitochondria and microbiota dysfunction in COVID-19 pathogenesis |
Neurodegeneration and mitochondria |
Variety of non-coding RNA imported and encoded in mitochondria Eric Barrey, University Paris-Saclay, INRAE, AgroParisTech, France
|
Molecular mechanisms of ncRNAs transport into mitochondria: emerging approaches and potential gene therapy applications |
Long non-coding RNA SAMMSON and beyond: Uncoupling cytosolic and mitochondrial-translation as an effective anti-melanoma strategy |
Targeting long non-coding mitochondrial RNA for cancer therapy |
Round table: Prospective on other mitochondrial gene therapies |
Mitochondrial disease community registry (MDCR): Perspectives from patients and families, lessons learned from the data Sophia Zilber, Boston, USA |